Novel syn intramolecular pathway in base-catalyzed 1,2-elimination reactions of beta-acetoxy esters.
As part of a comprehensive investigation of electronic effects on the stereochemistry of base-catalyzed 1,2-elimination reactions, we observed a new syn intramolecular pathway in the elimination of ...
ImmuneOnco has announced the dosing of the first patient in its Phase 1b/2 clinical trial of IMM2510/SYN-2510 combined with chemotherapy for advanced non-small cell lung cancer (NSCLC) in China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback